Onset and duration of action of levocabastine nasal spray in atopic patients under nasal challenge conditions
- 1 April 1999
- journal article
- clinical trial
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 103 (4) , 574-580
- https://doi.org/10.1016/s0091-6749(99)70226-5
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Onset of Action, Efficacy, and Safety of a Single Dose of Fexofenadine Hydrochloride for Ragweed Allergy Using an Environmental Exposure UnitAnnals of Allergy, Asthma & Immunology, 1997
- Onset of Action and Efficacy of Terfenadine, Astemizole, Cetirizine, and Loratadine for the Relief of Symptoms of Allergic RhinitisAnnals of Allergy, Asthma & Immunology, 1997
- A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial Comparing the Efficacy and Tolerability of Levocabastine-Oxymetazoline Nasal Spray with Levocabastine and Oxymetazoline Alone in the Symptomatic Treatment of Seasonal Allergic RhinitisAmerican Journal of Rhinology, 1996
- LevocabastineDrugs, 1995
- The Pharmacokinetic Properties of Topical LevocabastineClinical Pharmacokinetics, 1995
- Levocabastine: Pharmacological profile of a highly effective inhibitor of allergic reactionsInflammation Research, 1992
- LevocabastineDrugs, 1991
- Effects of topical treatment with H1 and H2 antagonists on clinical symptoms and nasal vascular reactions in patients with allergic rhinitisAllergy, 1989
- Antiallergic activity of H-receptor antagonists assessed by nasal challengeJournal of Allergy and Clinical Immunology, 1988
- Inhibition of histamine-induced nasal symptoms by the H1 antihistamine chloropheniramine maleate: Demonstration of topical effectRespiratory Medicine, 1983